Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression

Circulation Research

Volumn 83, Issue 10, 1998, Pages 1035-1046

  Tsutsumi, Yoshiaki ^a   Matsubara, Hiroaki ^a   Ohkubo, Naohiko ^a   Mori, Yasukiyo ^a   Nozawa, Yoshihisa ^b   Murasawa, Satoshi ^a   Kijima, Kazuhisa ^a   Maruyama, Katsuya ^a   Masaki, Hiroya ^a   Moriguchi, Yasutaka ^a   Shibasaki, Yasunobu ^a   Kamihata, Hiroshi ^a   Inada, Mitsuo ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Angiotensin II type 1 receptor; Angiotensin II type 2 receptor; AT2 receptor; AT1 receptor, angiotensin II

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; COLLAGEN TYPE 1; FIBRONECTIN; INOSITOL PHOSPHATE; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FIBROBLAST; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0032538950     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.10.1035     Document Type: Article

References (41)

1. Matsubara H, Inada M. Molecular insights into angiotensin II type 1 and type 2 receptors: expression, signaling and physiological function and clinical application of its antagonists. Endocr J. 1998;45:137-150.
2. Inagami T, Kitami Y. Angiotensin II receptor: molecular cloning, functions, and regulation. Hypertens Res. 1994;17:87-97.
3. Ichiki T, Labosky PA, Shiota C, Okuyama S, Inagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagami T. Effects on blood pressure and exploratory behavior of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
4. Hein L, Barsh GS, Pratt RE, Dzau VJ, Koblik BK. Behavioral and cardiovascular effects of disrupting angiotensin II type-2 receptor gene in mice. Nature. 1995;377:744-747.
5. Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H. Cardiac-specific overexpression of angiotensin AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 1998;101:527-535.
6. Nakajima M, Hutchinson HG, Hayashida W, Morishita R, Horiuchi M, Pratt RE, Dzau VJ. The angiotensin II type 2 (AT2) antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA. 1995;82:10663-10667.
7. Stoll M, Steckelings UM, Metzger RM, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
8. iα3 in the rat fetus. J Biol Chem. 1996;271:15026-15033.
9. + currents involves an inhibitory GTP binding protein. Am J Physiol. 1994;267:C1389-C1397.
10. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A. 1996;93:156-160.
11. Huang XC, Richards EM, Sumners C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptor and inhibited by angiotensin II type 2 receptors. J Biol Chem. 1996;271:15635-15641.
12. Grady EF, Sechi LA, Griffin CA, Schambolan M, Kalinucle JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991;88:901-933.
13. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II receptors in normal and failing human hearts. J Clin Endocrinol Metab. 1989;69:54-66.
14. Regitz-Zagrosek V, Friedel N, Heymann A, Bauer P, Neuss M, Rolfs A, Steffen C, Hildebrandt A, Hetzer R, Fleck E. Regulation, Chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation. 1995;91:1461-1471.
15. Asano K, Dutcher DL, Port JD, Minobe WA, Tremmel KD, Roden RL, Bohlmeyer TJ, Bush EW, Jenkin MJ, Abraham WT, Raynolds MV, Zisman LS, Perryman MB, Bristow MR. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation. 1997;95:1193-1200.
16. Wharton J, Morgan K, Rutherford RAD, Catravas JD, Chester A, Whitehead BF, Leval MR, Yacoub MH, Polak JM. Differential distribution of angiotensin AT2 receptor in the normal and failing human heart. J Pharmacol Exp Ther. 1994;270:566-571.
17. Rogg H, de Gasparo M, Graedel E, Stulz P, Burkart F, Eberhard M, Erne P. Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J. 1996;17:1112-1120.
18. Haywood GA, Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M, Fowler MB. AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation. 1997;95:1201-1206.
19. Christen Y, Waeber B, Nussberger J, Porchet M, Borland RM, Lee RJ, Maggon K, Shum L, Timmermans PB, Brunner HR. Oral administration of DuP 753, a specific angiotensin II receptor antagonist, to normal male volunteers. Inhibition of presser response to exogenous angiotensin I and II. Circulation. 1991;83:1333-1342.
20. Suzuki J, Matsubara H, Inada M. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993;73:439-447.
21. Nozawa Y, Haruno A, Oda N, Yamazaki Y, Suzuki H. Angiotensin II receptor subtypes in bovine and human ventricular myocardium. J Pharmacol Exp Ther. 1994;270:566-571.
22. Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Tsutsumi Y, Shibazaki Y, Iwasaka T, Inada M. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation. 1997;96:3954-3962.
23. Mori Y, Matsubara H, Murasawa S, Kijima K, Maruyama K, Hamakubo N, Inagami T, Iwasaka T, Inada M. Translational regulation of angiotensin II receptor: role of the upstream AUG triplets. Hypertension. 1996;28:810-817.
24. Murasawa S, Matsubara H, Kijima K, Maruyama K, Mori Y, Inada M. Structure of the V1a vasopressin receptor gene and characterization of its promoter region and complete cDNA sequence of the 3′-end. J Biol Chem. 1995;270:20042-20050.
25. Kizima K, Matsubara H, Murasawa S, Ohkubo N, Mori Y, Ohkubo N, Komuro I, Yazaki Y, Iwasaka T, Inada M. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res. 1996;79:887-897.
26. Kizima K, Matsubara H, Murasawa S, Inada M. Regulation of angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. Hypertension. 1996;27:529-534.
27. Berridge MJ. Rapid accumulation of inositol triphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J. 1983;212:849-858.
28. Baker KM, Campanile CP, Trachte GJ, Peach MJ. Identification and characterization of the rabbit angiotensin n myocardial receptor. Circ Res. 1984;54:286-293.
29. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Itoh H, Mukoyama M, Hosoda K, Yasue H, Imura H. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest. 1989;83:298-305.
30. Mukoyama M, Nakao K, Hosoda K, Saito Y, Ogawa Y, Yasue H, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest. 1991;87:1402-1412.
31. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849-1865.
32. Kim S, Miura K, Iwao H. Angiotensin II type 1 receptor blockade inhibits the expression of immediate-early genes and fibronectin in rat injured artery. Circulation. 1995;92:88-95.
33. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995;95:46-54.
34. Meggs LG, Coupet J, Huang H, Cheng W, Li P, Capasso JM, Homey CJ, Anversa P. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res. 1993;72:1149-1162.
35. Lefroy DC, Wharton J, Crake T, Knock G, Rutherford RAD, Suzuki T, Morgan K, Polak JM, Poole-Wilson PA. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J Mol Cell Cardiol. 1996;28:429-440.
36. Nakamura F, Nagano M, Kobayashi R, Higaki J, Mikami H, Kawaguchi N, Onishi S, Ogihara T. Chronic administration of angiotensin II receptor antagonist, TCV-116, in cardiomyopathic hamsters. Am J Physiol. 1994; 267:H2297-H2304.
37. de Gasparo M, Rogg H, Brink M, Wang L, Whitebread S, Bullock G, Erne P. Angiotensin II receptor subtypes and cardiac function. Eur Heart J. 1994;15(suppl D):98-103.
38. Brink M, Erne P, de Gasparo M, Rogg H, Schmid A, Stulz P, Bullock G. Localization of the angiotensin II receptor subtypes in the human atrium. J Mol Cell Cardiol. 1996;28:1789-1799.
39. Reiss K, Capasso JM, Huang H, Meggs LG, Li P, Anversa P. Ang II receptors c-myc, and c-jun in myocytes after myocardial infarction and ventricular failure. Am J Physiol. 1993;264:H760-H769.
40. Bristow MR, Ginsburg R, Minobe W, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
41. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania P, Ney DE, Snavely DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure (evaluation of losartan in the elderly study, ELITE). Lancet. 1997;349:747-752.